CN116829706A - 基于引导编辑的精确的基因组删除和替换方法 - Google Patents

基于引导编辑的精确的基因组删除和替换方法 Download PDF

Info

Publication number
CN116829706A
CN116829706A CN202180089154.0A CN202180089154A CN116829706A CN 116829706 A CN116829706 A CN 116829706A CN 202180089154 A CN202180089154 A CN 202180089154A CN 116829706 A CN116829706 A CN 116829706A
Authority
CN
China
Prior art keywords
domain
sequence
editing
editing complex
dsdna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202180089154.0A
Other languages
English (en)
Chinese (zh)
Inventor
J·A·申杜尔
W·陈
J·崔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WASHINGTON, University of
Original Assignee
WASHINGTON, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WASHINGTON, University of filed Critical WASHINGTON, University of
Publication of CN116829706A publication Critical patent/CN116829706A/zh
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
CN202180089154.0A 2020-11-05 2021-11-04 基于引导编辑的精确的基因组删除和替换方法 Withdrawn CN116829706A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063110304P 2020-11-05 2020-11-05
US63/110304 2020-11-05
PCT/US2021/058079 WO2022098885A1 (en) 2020-11-05 2021-11-04 Precise genome deletion and replacement method based on prime editing

Publications (1)

Publication Number Publication Date
CN116829706A true CN116829706A (zh) 2023-09-29

Family

ID=81458283

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180089154.0A Withdrawn CN116829706A (zh) 2020-11-05 2021-11-04 基于引导编辑的精确的基因组删除和替换方法

Country Status (6)

Country Link
US (1) US20240011055A1 (cg-RX-API-DMAC7.html)
EP (1) EP4240840A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023549125A (cg-RX-API-DMAC7.html)
CN (1) CN116829706A (cg-RX-API-DMAC7.html)
AU (1) AU2021376350A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022098885A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230091894A (ko) 2020-10-21 2023-06-23 메사추세츠 인스티튜트 오브 테크놀로지 부위 특이적 표적화 요소를 통한 프로그램 가능한 첨가(paste)를 사용하는 부위 특이적 유전 공학을 위한 시스템, 방법, 및 조성물
US20250354177A1 (en) * 2022-05-30 2025-11-20 Wuhan University System and methods for duplicating target fragments
WO2024233655A1 (en) * 2023-05-08 2024-11-14 Prime Medicine, Inc. Genome editing compositions and methods for treatment of fragile x syndrome

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3363902T3 (da) * 2012-12-06 2020-01-02 Sigma Aldrich Co Llc Crispr-baseret genommodifikation og -regulering
WO2017180711A1 (en) * 2016-04-13 2017-10-19 Editas Medicine, Inc. Grna fusion molecules, gene editing systems, and methods of use thereof
US20190330603A1 (en) * 2016-06-17 2019-10-31 Genesis Technologies Limited Crispr-cas system, materials and methods
CA3038982A1 (en) * 2016-09-30 2018-04-05 The Regents Of The University Of California Rna-guided nucleic acid modifying enzymes and methods of use thereof
JP2019532644A (ja) * 2016-09-30 2019-11-14 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Rna誘導型核酸修飾酵素及びその使用方法
WO2020191241A1 (en) * 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2021138469A1 (en) * 2019-12-30 2021-07-08 The Broad Institute, Inc. Genome editing using reverse transcriptase enabled and fully active crispr complexes
CA3177481A1 (en) * 2020-05-08 2021-11-11 David R. Liu Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence

Also Published As

Publication number Publication date
US20240011055A1 (en) 2024-01-11
AU2021376350A1 (en) 2023-06-22
AU2021376350A9 (en) 2024-06-13
EP4240840A4 (en) 2025-01-01
JP2023549125A (ja) 2023-11-22
WO2022098885A1 (en) 2022-05-12
EP4240840A1 (en) 2023-09-13

Similar Documents

Publication Publication Date Title
Tao et al. Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites
Zong et al. An engineered prime editor with enhanced editing efficiency in plants
Xu et al. Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing
Zhang et al. Increasing the efficiency and targeting range of cytidine base editors through fusion of a single-stranded DNA-binding protein domain
Anzalone et al. Search-and-replace genome editing without double-strand breaks or donor DNA
CN112823011B (zh) 基于t细胞的免疫疗法的基因靶标
Shayevitch et al. The importance of DNA methylation of exons on alternative splicing
US12065667B2 (en) Modified Cpf1 MRNA, modified guide RNA, and uses thereof
AU2019408503B2 (en) Compositions and methods for highly efficient genetic screening using barcoded guide rna constructs
Klann et al. CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome
Xie et al. High-fidelity SaCas9 identified by directional screening in human cells
EP3374507A1 (en) Crispr-cas sgrna library
US20240011055A1 (en) Precise genome deletion and replacement method based on prime editing
JP7244885B2 (ja) 機能的なIncRNAをスクリーニングおよび同定するための方法
WO2023016021A1 (zh) 一种碱基编辑工具及其构建方法
JP2026048971A (ja) 「CTL-seq」(CRISPR Tag Linear-seq)と称するヌクレアーゼオン/オフターゲット編集位置を指定するための方法
Ryu et al. Rapid, accurate mapping of transgene integration in viable rhesus macaque embryos using enhanced-specificity tagmentation-assisted PCR
Zhou et al. Robust regulatory interplay of enhancers, facilitators, and promoters in a native chromatin context
Levesque et al. In cellulo DNA assembly for targeted genomic integration and rearrangement in human cells
Sun et al. From genomic fossils to functional elements: the evolving story of pseudogenes
Martin et al. 3'end sequencing library preparation with A-seq2
Gehrke et al. High-precision CRISPR-Cas9 base editors with minimized bystander and off-target mutations
Chen et al. Structure‐guided engineering of a Cas12i nuclease unlocks near‐PAMless genome editing
Tang et al. Target-seq: single workflow for detection of genome integration site, DNA translocation and off-target events
Ma et al. Base-editor-mediated circRNA knockout by targeting predominantly back-splice sites

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20230929